Advertisement
Advertisement
Advertisement
Home arrow News arrow Science arrow Tipping the scales genetically
Tipping the scales genetically
At the center of a controversy over whether genetically modified salmon should be sold for consumption is a tiny Waltham company that has spent 15 years and $60 million working on the project.
 

AquaBounty Technologies, using a growth hormone gene from the Chinook salmon, has created an Atlantic salmon that grows twice as fast as the conventional fish. It reaches full size in about 18 months, rather than the standard three years.

The company calls it AquAdvantage salmon. Concerned groups declared it “Frankenfish.’’

Earlier this month, the US Food and Drug Administration proclaimed the fish safe to eat, and public hearings took place this week. Opposition was swift and vocal. Critics say it poses risks to consumer health and the environment. They rallied in front of the White House, and a coalition has gathered more than 170,000 signatures in protest.

Read the complete story from The Boston Globe.

 

 

 

 

 

 

Bookmark and Share Print
 

MELISSA WOOD, NATIONAL FISHERMEN: Meting out the meager

May 22, 2012 - Listening to the New England Council's Groundfish Advisory Panel talk about how that industry is going to pay for monitoring costs is kind of like trying to figure out how to pay your bills when you've just lost your job. Though monitoring is important keeping costs down is critical. As Panel Member Gary Libby pointed out, "If we had 100 percent monitoring we probably wouldn't have an industry."